N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer

Oncogene

Volumn 31, Issue 41, 2012, Pages 4484-4489

  Su, Y ^a   Li, J ^a   Witkiewicz, A K ^b   Brennan, D ^a   Neill, T ^a   Talarico, J ^a   Radice, G L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

apoptosis; cell adhesion; invasion; matrix metalloproteinase

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MATRILYSIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; SONIC HEDGEHOG PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER MODEL; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC MANIPULATION; HAPLOINSUFFICIENCY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; CADHERINS; CARCINOMA, PANCREATIC DUCTAL; CASPASE 3; CELL PROLIFERATION; CELL SURVIVAL; FIBROBLAST GROWTH FACTORS; HAPLOINSUFFICIENCY; HUMANS; KAPLAN-MEIER ESTIMATE; MATRIX METALLOPROTEINASE 7; MICE; MICE, TRANSGENIC; MUTATION, MISSENSE; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; ERINACEIDAE; MURINAE; MUS;

EID: 84867402835     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.574     Document Type: Article

References (31)

1. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006; 20: 1218-1249. (Pubitemid 43727584)
2. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci 2008; 121(Part 6): 727-735. (Pubitemid 351578108)
3. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000; 148: 779-790.
4. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999; 147: 631-644.
5. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4: 437-450. (Pubitemid 38050041)
6. Agbunag C, Bar-Sagi D. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Cancer Res 2004; 64: 5659-5663. (Pubitemid 39095562)
7. Brembeck FH, Schreiber FS, Deramaudt TB, Craig L, Rhoades B, Swain G et al. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res 2003; 63: 2005-2009. (Pubitemid 36538597)
8. Deramaudt TB, Takaoka M, Upadhyay R, Bowser MJ, Porter J, Lee A et al. N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption. Mol Cell Biol 2006; 26: 4185-4200. (Pubitemid 43788020)
9. Shintani Y, Hollingsworth MA, Wheelock MJ, Johnson KR. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res 2006; 66: 11745-11753. (Pubitemid 46094186)
10. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 2005; 7: 469-483. (Pubitemid 40719130)
11. Kostetskii I, Li J, Xiong Y, Zhou R, Ferrari VA, Patel VV et al. Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res 2005; 96: 346-354. (Pubitemid 40279909)
12. Luo Y, Kostetskii I, Radice GL. N-cadherin is not essential for limb mesenchymal chondrogenesis. Dev Dyn 2005; 232: 336-344. (Pubitemid 40129786)
13. Johansson JK, Voss U, Kesavan G, Kostetskii I, Wierup N, Radice GL et al. Ncadherin is dispensable for pancreas development but required for beta-cell granule turnover. Genesis 2010; 48: 374-381.
14. Shintani Y, Fukumoto Y, Chaika N, Grandgenett PM, Hollingsworth MA, Wheelock MJ et al. ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression. Int J Cancer 2008; 122: 71-77. (Pubitemid 350209980)
15. Suyama K, Shapiro I, Guttman M, Hazan RB. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2002; 2: 301-314. (Pubitemid 41043964)
16. Schreiber FS, Deramaudt TB, Brunner TB, Boretti MI, Gooch KJ, Stoffers DA et al. Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene. Gastroenterology 2004; 127: 250-260. (Pubitemid 38962292)
17. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425: 846-851. (Pubitemid 37351469)
18. Morton JP, Mongeau ME, Klimstra DS, Morris JP, Lee YC, Kawaguchi Y et al. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci USA 2007; 104: 5103-5108. (Pubitemid 47186183)
19. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425: 851-856. (Pubitemid 37355945)
20. Karafin MS, Cummings CT, Fu B, Iacobuzio-Donahue CA. The developmental transcription factor Gata4 is overexpressed in pancreatic ductal adenocarcinoma. Int J Clin Exp Pathol 2009; 3: 47-55.
21. Crawford HC, Scoggins CR, Washington MK, Matrisian LM, Leach SD. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 2002; 109: 1437-1444. (Pubitemid 34596169)
22. Fukuda A, Wang SC, Morris IV JP, Folias AE, Liou A, Kim GE et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011; 19: 441-455.
23. Nomura S, Yoshitomi H, Takano S, Shida T, Kobayashi S, Ohtsuka M et al. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. Br J Cancer 2008; 99: 305-313.
24. Cavallaro U, Niedermeyer J, Fuxa M, Christofori G. N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat Cell Biol 2001; 3: 650-657. (Pubitemid 32624421)
25. Lehembre F, Yilmaz M, Wicki A, Schomber T, Strittmatter K, Ziegler D et al. NCAMinduced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J 2008; 27: 2603-2615.
26. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D et al. Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009; 324: 1457-1461.
27. Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W et al. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res 2007; 67: 3106-3116. (Pubitemid 46724847)
28. Kang JS, Feinleib JL, Knox S, Ketteringham MA, Krauss RS. Promyogenic members of the Ig and cadherin families associate to positively regulate differentiation. Proc Natl Acad Sci USA 2003; 100: 3989-3994. (Pubitemid 36418144)
29. Tenzen T, Allen BL, Cole F, Kang JS, Krauss RS, McMahon AP. The cell surface membrane proteins Cdo and Boc are components and targets of the hedgehog signaling pathway and feedback network in mice. Dev Cell 2006; 10: 647-656.
30. Augustine CK, Yoshimoto Y, Gupta M, Zipfel PA, Selim MA, Febbo P et al. Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res 2008; 68: 3777-3784.
31. Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T et al. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 2010; 16: 1414-1420.